Linzess is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Linaclotide.
Product ID | 0456-1203_114152bc-d286-4228-9b01-9814473d3875 |
NDC | 0456-1203 |
Product Type | Human Prescription Drug |
Proprietary Name | Linzess |
Generic Name | Linaclotide |
Dosage Form | Capsule, Gelatin Coated |
Route of Administration | ORAL |
Marketing Start Date | 2017-01-30 |
Marketing Category | NDA / NDA |
Application Number | NDA202811 |
Labeler Name | Allergan, Inc. |
Substance Name | LINACLOTIDE |
Active Ingredient Strength | 72 ug/1 |
Pharm Classes | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-01-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202811 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-01-30 |
Marketing Category | NDA |
Application Number | NDA202811 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-01-30 |
Ingredient | Strength |
---|---|
LINACLOTIDE | 72 ug/1 |
SPL SET ID: | 09beda19-56d6-4a56-afdc-9a77b70b2ef3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0456-1201 | Linzess | linaclotide |
0456-1202 | Linzess | linaclotide |
0456-1203 | Linzess | linaclotide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LINZESS 85773175 4614364 Live/Registered |
Ironwood Pharmaceuticals, Inc. 2012-11-06 |
LINZESS 77872111 4328588 Live/Registered |
Ironwood Pharmaceuticals, Inc. 2009-11-13 |